|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.100 EUR | 0.00% |
|
0.00% | -7.79% |
| 02-26 | EARNINGS AND TRADING: Connecting Excellence hails record January fees | AN |
| 02-26 | Malin Corporation says CEO Fiona Dunlevy will leave Malin end of May | RE |
| Market Cap | 30.78M 35.47M 28.82M 26.36M 49.77M 3.38B 50.42M 337M 132M 1.69B 133M 130M 5.62B | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 17.88M 20.6M 16.74M 15.31M 28.91M 1.96B 29.29M 196M 76.87M 981M 77.36M 75.67M 3.26B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 month | -2.07% | ||
| 3 months | -10.69% | ||
| 6 months | -8.97% | ||
| Current year | -7.79% |
| 1 week | 7.1 |  | 7.15 |
| 1 month | 7.1 | | 7.25 |
| Current year | 7 | | 8.45 |
| 1 year | 7 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 14.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 2019-08-01 |
| Director/Board Member | 67 | 2018-07-15 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 2018-07-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/28/25 | Fiscal year | Chief Executive Officer | 5,746 | 0.1328% | ||
| 4/7/25 | Sell | Director | 11,075 | 0.2560% | ||
| 4/7/25 | Sell | Chief Executive Officer | 17,780 | 0.4110% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -8.97% | +62.84% | 35.47M | |
| -0.19% | +2.49% | +83.73% | +159.30% | 1,062B | |
| +0.15% | +0.31% | +49.92% | +48.56% | 619B | |
| +0.63% | -2.06% | +23.59% | +63.49% | 431B | |
| +1.88% | +5.03% | +49.10% | +40.23% | 358B | |
| +1.17% | -0.13% | +35.88% | +40.72% | 293B | |
| +1.26% | -4.96% | +9.64% | +10.29% | 247B | |
| +0.94% | +5.46% | +42.68% | +60.59% | 219B | |
| +3.74% | -0.72% | -1.47% | -44.24% | 200B | |
| +1.59% | +2.07% | +20.51% | +64.75% | 162B | |
| Average | +1.12% | -1.71% | +30.46% | +50.65% | 359.23B | |
| Weighted average by Cap. | +0.76% | -0.83% | +48.13% | +75.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -6.9M -7.95M -6.46M -5.91M -11.16M -757M -11.3M -75.59M -29.66M -378M -29.85M -29.2M -1.26B |
| Net Debt | -62.1M -71.56M -58.15M -53.19M -100M -6.82B -102M -680M -267M -3.41B -269M -263M -11.34B | -12.9M -14.87M -12.08M -11.05M -20.86M -1.42B -21.13M -141M -55.46M -707M -55.81M -54.6M -2.35B |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | €7.100 | 0.00% | 246 |
| 26-08-06 | €7.100 | 0.00% | 0 |
| 26-08-05 | €7.100 | -0.70% | 30 |
| 26-08-04 | €7.150 | 0.00% | 0 |
| 26-08-03 | €7.150 | +0.70% | 1 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.100EUR
Average target price
15.50EUR
Spread / Average Target
+118.31%
- Stock Market
- Stocks
- MLC Stock
Select your edition
All financial news and data tailored to specific country editions
